FI951760A0 - Gestageenisesti vaikuttavat 19,11-silloitetut 4-estreenit - Google Patents

Gestageenisesti vaikuttavat 19,11-silloitetut 4-estreenit

Info

Publication number
FI951760A0
FI951760A0 FI951760A FI951760A FI951760A0 FI 951760 A0 FI951760 A0 FI 951760A0 FI 951760 A FI951760 A FI 951760A FI 951760 A FI951760 A FI 951760A FI 951760 A0 FI951760 A0 FI 951760A0
Authority
FI
Finland
Prior art keywords
gestagent
estrener
crosslinked
acting
production
Prior art date
Application number
FI951760A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI951760A7 (fi
FI951760L (fi
Inventor
Eckhard Ottow
Wolfgang Schwede
Wolfgang Halfbrodt
Karl-Heinrich Fritzemeier
Rolf Krattenmacher
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI951760A7 publication Critical patent/FI951760A7/fi
Publication of FI951760L publication Critical patent/FI951760L/fi
Publication of FI951760A0 publication Critical patent/FI951760A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Investigation Of Foundation Soil And Reinforcement Of Foundation Soil By Compacting Or Drainage (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Glass Compositions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Eye Examination Apparatus (AREA)
  • Toys (AREA)
FI951760A 1992-10-13 1993-10-13 Gestageenisesti vaikuttavat 19,11-silloitetut 4-estreenit FI951760A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4235220A DE4235220A1 (de) 1992-10-13 1992-10-13 Gestagen wirksame 19,11ß-überbrückte 4-Estrene
PCT/EP1993/002823 WO1994009025A1 (de) 1992-10-13 1993-10-13 Gestagen wirksame 19,11-überbrückte 4-estrene

Publications (3)

Publication Number Publication Date
FI951760A7 FI951760A7 (fi) 1995-04-12
FI951760L FI951760L (fi) 1995-04-12
FI951760A0 true FI951760A0 (fi) 1995-04-12

Family

ID=6470806

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951760A FI951760A0 (fi) 1992-10-13 1993-10-13 Gestageenisesti vaikuttavat 19,11-silloitetut 4-estreenit

Country Status (25)

Country Link
US (2) US5523298A (cs)
EP (1) EP0664811B1 (cs)
JP (1) JP3302366B2 (cs)
KR (1) KR100341066B1 (cs)
CN (1) CN1052238C (cs)
AT (1) ATE156837T1 (cs)
AU (1) AU677019B2 (cs)
BR (1) BR9307232A (cs)
CA (1) CA2146962A1 (cs)
CZ (1) CZ284187B6 (cs)
DE (2) DE4235220A1 (cs)
DK (1) DK0664811T3 (cs)
ES (1) ES2108298T3 (cs)
FI (1) FI951760A0 (cs)
GR (1) GR3024940T3 (cs)
HU (1) HU223315B1 (cs)
IL (1) IL107232A (cs)
NO (1) NO305440B1 (cs)
NZ (1) NZ256865A (cs)
PL (1) PL179764B1 (cs)
RU (1) RU2157814C2 (cs)
SK (1) SK280991B6 (cs)
TW (1) TW341575B (cs)
WO (1) WO1994009025A1 (cs)
ZA (1) ZA937614B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4235220A1 (de) * 1992-10-13 1994-06-16 Schering Ag Gestagen wirksame 19,11ß-überbrückte 4-Estrene
DE4413185A1 (de) * 1994-04-12 1995-10-19 Schering Ag 11beta,19-überbrückte 13alpha-Alkylsteroide
DE4413184A1 (de) * 1994-04-12 1995-10-19 Schering Ag 10,11-C¶3¶-überbrückte Steroide
US5912006A (en) * 1996-08-28 1999-06-15 Eboc, Inc. Compositions and methods for alleviating discomforting menstrual pain
EP1373888A2 (en) * 2000-12-28 2004-01-02 Schering Aktiengesellschaft Method for screening for progesterone receptor isoform-specific ligands
US20040121304A1 (en) * 2001-12-21 2004-06-24 Ulrike Fuhrmann Method for screening for progesterone receptor isoform-specific ligands and for tissue-selective progesterone receptor ligands
GB0219345D0 (en) * 2002-08-20 2002-09-25 Givaudan Sa Improvements in or relating to organic compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU139639A1 (ru) * 1960-03-28 1960-11-30 Н.В. Маревич Крепь дл поддержани междуэтажных целиков при щитовой системе разработки
US3465010A (en) * 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
US4361559A (en) * 1981-08-20 1982-11-30 E. R. Squibb & Sons, Inc. Antiinflammatory 17,17-bis (substituted thio) androstenes
DE3708942A1 (de) * 1987-03-18 1988-09-29 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
US5446178A (en) * 1987-03-18 1995-08-29 Schering Aktiengesellschaft Process for preparing 19,11β-bridged steroids
DE3717169A1 (de) * 1987-05-19 1988-12-01 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3832303A1 (de) * 1988-09-20 1990-04-12 Schering Ag 11ss-phenyl-14ssh-steroide
DE3917274A1 (de) * 1989-05-24 1990-11-29 Schering Ag 9(alpha)-hydroxy-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4038128A1 (de) * 1990-11-27 1992-06-04 Schering Ag 8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4235220A1 (de) * 1992-10-13 1994-06-16 Schering Ag Gestagen wirksame 19,11ß-überbrückte 4-Estrene

Also Published As

Publication number Publication date
JP3302366B2 (ja) 2002-07-15
NO951444L (no) 1995-06-13
EP0664811B1 (de) 1997-08-13
KR950703576A (ko) 1995-09-20
HU223315B1 (hu) 2004-05-28
CA2146962A1 (en) 1994-04-28
FI951760A7 (fi) 1995-04-12
FI951760L (fi) 1995-04-12
IL107232A (en) 1998-06-15
WO1994009025A1 (de) 1994-04-28
PL179764B1 (pl) 2000-10-31
US5703066A (en) 1997-12-30
AU5177493A (en) 1994-05-09
AU677019B2 (en) 1997-04-10
RU95109891A (ru) 1997-02-10
NO951444D0 (no) 1995-04-12
ATE156837T1 (de) 1997-08-15
CZ284187B6 (cs) 1998-09-16
NZ256865A (en) 1996-04-26
CZ91995A3 (en) 1995-09-13
CN1052238C (zh) 2000-05-10
JPH08502276A (ja) 1996-03-12
BR9307232A (pt) 1999-08-24
ZA937614B (en) 1994-05-23
IL107232A0 (en) 1994-01-25
PL308349A1 (en) 1995-07-24
CN1092428A (zh) 1994-09-21
SK280991B6 (sk) 2000-10-09
DE59307133D1 (de) 1997-09-18
DE4235220A1 (de) 1994-06-16
DK0664811T3 (da) 1998-03-30
HU9501057D0 (en) 1995-06-28
ES2108298T3 (es) 1997-12-16
SK49495A3 (en) 1995-08-09
US5523298A (en) 1996-06-04
RU2157814C2 (ru) 2000-10-20
GR3024940T3 (en) 1998-01-30
NO305440B1 (no) 1999-05-31
TW341575B (en) 1998-10-01
EP0664811A1 (de) 1995-08-02
HUT71523A (en) 1995-12-28
KR100341066B1 (ko) 2002-12-06

Similar Documents

Publication Publication Date Title
BR9408246A (pt) Composto derivado de 3-azabicicloalcano N-substituído
EP0482410A3 (en) Anti-microbial compounds, including substituted 2-cyclohexyl-amine derivatives and their preparation
DE69615682D1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide
MX9805181A (es) Derivados de lactona a partir de derivados de 17.beta- carboxi, carbotio y amida androstano.
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
ES2153975T3 (es) Derivados de pirimidona con actividad antifungica.
EP0833819A4 (en) N- (2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3-YL) -3-AMIDE
IL98262A0 (en) Chromone derivatives and pharmaceutical compositions containing them
DK0832075T3 (da) N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzo-diazepin-3-yl)-3-amider
NO981393D0 (no) Guanidinoproteasehemmere
FI951760A0 (fi) Gestageenisesti vaikuttavat 19,11-silloitetut 4-estreenit
ATE236888T1 (de) N-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5- benzodiazepin-3-yl)-3-amide
ES2104682T3 (es) Fluor-compuestos.
TW252979B (cs)
ES2104509A1 (es) Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
ES2098338T3 (es) Heteroarilmetilbencenos.
ATE80629T1 (de) Beta-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln.
ES2101644A1 (es) Nuevo compuesto derivado del cromeno
IL140919A0 (en) N-substituted azabicycloheptane derivatives, production and use thereof